Patient Characteristics
| Patient No. . | Age/Sex . | Diagnosis . | Presentation . | WBC (×109/L) . | Cytogenetics . |
|---|---|---|---|---|---|
| 1 | 20/M | ALL-early B | Relapse | 830 | t(4;11)(q21;q23) |
| t(der4;11)(q21;p13) | |||||
| 2 | 24/M | ALL-T cell | Relapse | 77.8 | Normal |
| 3 | 70/M | AML/RAEBit | Relapse | 21.3 | ND |
| 4 | 19/M | ALL-early B | De novo | 3.0 | Complex, including −8,−13,der(14), t(8;14)(q11;q31) |
| 5 | 48/F | AML (M2) | De novo | 21.9 | Normal |
| 6 | 61/M | MBC/CGL | De novo | 2.4 | t(9;22)(q34;q11) |
| 7 | 15/M | AML/ALL | De novo | 302 | Normal |
| 8 | 17/M | ALL-early B | Relapse | 31.2 | +21 |
| 9 | 12/M | AML/ALL | De novo | 66.6 | del(9) |
| 10 | 31/M | APL (M3) | Relapse | 50.5 | ND |
| 11 | 78/M | AML (NOS) | De novo | 30.1 | Normal |
| 12 | 30/F | AML (M4) | Relapse | 16.7 | +8 |
| 13 | 3/M | AMMoL (M5a) | De novo | 159 | Normal |
| 14 | 46/F | AML (M2) | Relapse | 6.0 | −7 |
| Patient No. . | Age/Sex . | Diagnosis . | Presentation . | WBC (×109/L) . | Cytogenetics . |
|---|---|---|---|---|---|
| 1 | 20/M | ALL-early B | Relapse | 830 | t(4;11)(q21;q23) |
| t(der4;11)(q21;p13) | |||||
| 2 | 24/M | ALL-T cell | Relapse | 77.8 | Normal |
| 3 | 70/M | AML/RAEBit | Relapse | 21.3 | ND |
| 4 | 19/M | ALL-early B | De novo | 3.0 | Complex, including −8,−13,der(14), t(8;14)(q11;q31) |
| 5 | 48/F | AML (M2) | De novo | 21.9 | Normal |
| 6 | 61/M | MBC/CGL | De novo | 2.4 | t(9;22)(q34;q11) |
| 7 | 15/M | AML/ALL | De novo | 302 | Normal |
| 8 | 17/M | ALL-early B | Relapse | 31.2 | +21 |
| 9 | 12/M | AML/ALL | De novo | 66.6 | del(9) |
| 10 | 31/M | APL (M3) | Relapse | 50.5 | ND |
| 11 | 78/M | AML (NOS) | De novo | 30.1 | Normal |
| 12 | 30/F | AML (M4) | Relapse | 16.7 | +8 |
| 13 | 3/M | AMMoL (M5a) | De novo | 159 | Normal |
| 14 | 46/F | AML (M2) | Relapse | 6.0 | −7 |
Abbreviations: AML, acute myelocytic leukemia; RAEBit, refractory anemia with excess blasts in transformation; MBC, myeloid blast crisis; CGL, chronic granulocytic leukemia; AML/ALL, biphenotypic acute leukemia; APL, acute promyelocytic leukemia; AMMoL, acute myelomonocytic leukemia; NOS, not otherwise specified; ND, not done.